Market revenue in 2023 | USD 8,429.5 million |
Market revenue in 2030 | USD 15,108.1 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Chemotherapy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.62% in 2023. Horizon Databook has segmented the Europe home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for a significant market share in 2021 owing to factors such as increasing geriatric population and rising prevalence of diseases that require infusion therapy. Increase in the number of disabled individuals participating in the workforce, growing incidence of birth defects & disabilities in children, and introduction of disability laws to enable individuals to enjoy a normal lifestyle & social status are some of the additional factors expected to drive the sales of home infusion therapies in European countries.
Limited insurance coverage for home healthcare in the region is expected to create huge growth opportunities for players in the European home infusion therapy market. The imminent implementation of In-vitro Diagnostics Regulation (IVDR) and new Medical Device Regulation (MDR) is anticipated to drastically change medical device regulatory scenario in the European Union.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe home infusion therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Europe home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account